We have the potential to radically extend human healthspan in the coming decades using epigenetic reprogramming. Check out NewLimit's 2025 Progress Update. Incredibly exciting.

happy to share an update on our recent progress NewLimit feat. Brian Armstrong, Blake Byers, Cathy O'Hare, & myself we're starting to see the first hints of viable therapeutics for aging through reprogramming. if this excites you, come join us!

👀

We’ve raised a $130 million Series B led by Kleiner Perkins alongside new investors Nat Friedman/Daniel Gross , Vinod Khosla, and HUMAN CAPITAL — joined by existing investors Founders Fund , DIMENSION, and Brian Armstrong (yes, the cofounders are doubling down). We also raised

Congrats to the entire team at @NewLimit, led by Jacob Kimmel, Cathy O'Hare, and Blake Byers who deserve the credit for making this milestone possible! Exciting progress, and lots to build.

the best days are ahead NewLimit

𝐂𝐨𝐦𝐩𝐚𝐧𝐲 𝐍𝐞𝐰𝐬: NewLimit raised a $130M series B round last week to advance its work using epigenetic reprogramming to improve cell function and thus aim to extend longevity. Full video: biotechtv.com/post/newlimit-…

this summer NewLimit, we built our first prototype medicine that restores multiple youthful functions in old hepatocytes. rejuvenating old cells across multiple dimensions seems more possible today than just months ago. recent highlights - +3 TF sets that restore function in

The research NewLimit over the last quarter has moved my probability that Aging is reversible to 90% and that anti-Aging Medicines will exist to 70%. Still a lot of work to do! That age is a ~plastic state continues to be the secret that the team NewLimit believes while ~the

Important updates from NewLimit on our progress toward curing aging (or at least restoring function that your cells had when you were younger). This is one of the most important and ambitious projects to benefit humanity. Visit the NewLimit careers page on our website to work

NewLimit paper just dropped ICML Conference showing our SOTA AI models can predict perturbed cell states. Helps to have the largest primary cell perturbation dataset in the world. Bonus points for one of the first demonstration of active learning in bio.

reprogramming cells with transcription factors is our most expressive tool for engineering cell state traditionally, we found TFs by ~guesswork ICML Conference we're sharing NewLimit's SOTA AI models that can design reprogramming payloads by building on molecular foundation models

ashlee & the Core Memory team are among the best storytellers in science. we were privileged to host them for a look inside NewLimit. we hope this is only the first of many windows into our mission to add healthy years to each life.

great overview of DIMENSION portco NewLimit, pioneering tech in epigenetic reprogramming to ̶s̶l̶o̶w̶ reverse aging in pursuit of future life saving, life extending, medicines